Literature DB >> 1925979

Developmental regulation for collagen II gene expression in transgenic mice.

L A Bruggeman1, H X Xie, K S Brown, Y Yamada.   

Abstract

In order to evaluate the involvement of the type II collagen regulatory sequences in development, we have injected a construct containing a toxin gene under the control of the rat type II collagen promoter and enhancer. The construct, pDAS10-DTA, contained the diphtheria toxin A chain gene under the control of type II collagen sequences which had been used previously to target cartilagenous tissues in transgenics. Inspection of developing fetuses at various stages of gestation revealed a high number of aborted implants as well as abnormally developing fetuses. These abnormal fetuses were of small size, had shortened and underdeveloped limbs, cleft palates, and generally resembled a phenotype similar to chondrodystrophic mice. Histological comparisons of normal and abnormal fetuses indicated a reduced amount of extracellular matrix surrounding chondrocytes, and a disorganized appearance of the tissue. These results suggest that the expression of the toxin has occurred in chondrocytes and altered the survival and development of the transgenic mice. These results also indicate that the promoter and enhancer sequences contained in the transgene controlled the developmental expression of the type II collagen gene expression.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1925979     DOI: 10.1002/tera.1420440208

Source DB:  PubMed          Journal:  Teratology        ISSN: 0040-3709


  3 in total

1.  Induction of an osteoarthritis-like phenotype and degradation of phosphorylated Smad3 by Smurf2 in transgenic mice.

Authors:  Qiuqian Wu; Kyung-Ok Kim; Erik R Sampson; Di Chen; Hani Awad; Todd O'Brien; J Edward Puzas; Hicham Drissi; Edward M Schwarz; Regis J O'Keefe; Michael J Zuscik; Randy N Rosier
Journal:  Arthritis Rheum       Date:  2008-10

2.  Positive-negative selection gene targeting with the diphtheria toxin A-chain gene in mouse embryonic stem cells.

Authors:  J W McCarrick; J R Parnes; R H Seong; D Solter; B B Knowles
Journal:  Transgenic Res       Date:  1993-07       Impact factor: 2.788

3.  The clinical features of spondyloepiphyseal dysplasia congenita resulting from the substitution of glycine 997 by serine in the alpha 1(II) chain of type II collagen.

Authors:  W G Cole; R K Hall; J G Rogers
Journal:  J Med Genet       Date:  1993-01       Impact factor: 6.318

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.